#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sickle cell anaemia Mitochondrial DNA depletion Toxic epidermal necrolysis Biliary cancer metastatic Erdheim-Chester disease Cutaneous T-cell lymphoma recurrent Progressive supranuclear palsy Obliterative bronchiolitis Niemann-Pick disease Systemic scleroderma Factor VIII deficiency Marginal zone lymphoma Exudative retinopathy Hepatoblastoma Ewing's sarcoma recurrent More trials…

    Learn about Rare Diseases

    Glycogen storage disease type V – Life with Disease Rhabdomyosarcoma – Diagnostics Langerhans’ cell histiocytosis Gastrointestinal stromal tumour – Life with Disease Advanced systemic mastocytosis – Treatment Haemolytic uraemic syndrome Mantle cell lymphoma stage II – Diagnostics Mucopolysaccharidosis II – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Rosai-Dorfman syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gefitinib Corline Heparin Conjugate LTG-001 1,3-BUTYLENE GLYCOL Levocetirizine Dihydrochloride Glasdegib Progesterone Tryptophan Patritumab Deruxtecan Specific Nucleic Acid Sna-Veru Etuvetidigene Autotemcel Esomeprazole Magnesium Abc-35B-116 AZD4512 Oxazepam Ritonavir Co-Trimoxazole Relebactam A/H1N1 INFLUENZA VACCINE Vatiquinone More therapies…

    Learn about Your Condition

    Lupus nephritis Lung adenocarcinoma stage IV Inborn error of metabolism Lichenoid keratosis Loeys-Dietz syndrome Stress Arteriovenous graft thrombosis Choreoathetosis Round cell liposarcoma Breast proliferative changes Osteogenesis imperfecta Penile cancer Ischaemic skin ulcer Mitral valve prolapse Glaucoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. InterHem Poradnie Specjalistyczne

InterHem Poradnie Specjalistyczne

Ul. Choroszczanska 24, Bialystok, 15-732, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Loperamide Hydrochloride
    • Navtemadlin
    • Ondansetron
    Austria Belgium Croatia Czechia France Germany +7

  • Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Zanubrutinib
    Czechia France Germany Greece Italy The Netherlands +3

  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Other Analgesics And Antipyretics
    • Secukinumab
    Denmark Greece Hungary Italy Poland Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!